Skip to content
Tissue
Hard palate, salivary gland
Disease
Hard palate mucoepidermoid carcinoma
Metastatic site
Primary tumor site (hard palate)
Synonyms
University of Michigan-Human Mucoepidermoid Carcinoma-3B

Documents

UM-HMC-3B

Cell line · Product number 305715

€0.00excl. tax and shipping

Customization / Recommendations

In stock
Lot
Recommended (freshest lot)
1

01General information

Description

UM-HMC-3B is a human mucoepidermoid carcinoma cell line established from a primary mucoepidermoid carcinoma of the hard palate salivary glands of a 73-year-old Caucasian female patient. The line is is part of the University of Michigan Human Mucoepidermoid Carcinoma (UM-HMC) panel. Like UM-HMC-1, UM-HMC-3B harbors the CRTC1-MAML2 gene fusion (MECT1-MAML2), the oncogenic driver in the majority of mucoepidermoid carcinomas, which results from a t(11;19)(q21;p13) translocation and drives CREB and Notch pathway activation.

UM-HMC-3B is applicable in studies of hard palate and salivary gland mucoepidermoid carcinoma biology, CRTC1-MAML2 signalling, and comparative analyses with other UM-HMC panel lines. Together with UM-HMC-1 and other panel members, UM-HMC-3B enables identification of common and divergent molecular features across mucoepidermoid carcinomas of different anatomical sites, ages, and genders. It is also suitable for drug sensitivity assays targeting fusion oncoproteins and downstream CREB/Notch effectors.

Tissue
Hard palate, salivary gland
Disease
Hard palate mucoepidermoid carcinoma
Metastatic site
Primary tumor site (hard palate)
Applications
Salivary gland carcinoma research; CRTC1-MAML2 fusion biology; hard palate MEC biology; CREB/Notch pathway; comparative UM-HMC panel studies; drug sensitivity assays
Synonyms
  • University of Michigan-Human Mucoepidermoid Carcinoma-3B

02Classification

Organism
Human
Sex
Female
Growth properties
Adherent
GMO status
Non-GMO
GMO status details
No genetic modification; somatic CRTC1-MAML2 fusion acquired during tumor development
Biosafety level
1

03Characteristics

Morphology
Epithelial-like
Cell type
Epithelial cells
Doubling time
approx. 24 to 48 hours

04Identifiers

Citation
UM-HMC-3B (Cytion catalog number 305715)
NCBI TaxID
9606
Cellosaurus
CVCL_Y472

05Expression and susceptibility

Mutational profile
Mutation: Gene fusion, CRTC1 + HGNC, MAML2, Name(s)=CRTC1-MAML2, MECT1-MAML2.

06Handling and culture

Culture medium
DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Incubation atmosphere

37°C, 5% CO2, humidified atmosphere.

Supplements
Supplement the medium with 10% FBS
Dissociation reagent
Accutase
Subculturing
Remove medium, wash with PBS without calcium and magnesium, cover with Accutase, incubate 8–10 min at RT, resuspend in medium, centrifuge 300×g 3 min, discard supernatant, reseed in fresh medium.
Split ratio
1 to 5
Seeding density
1 to 3 × 10⁴ cells/cm²
Fluid renewal
Every 2 to 3 days
Thawing and culturing
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.

  7. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.

  8. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.

07Quality control and cryopreservation

Sterility

Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods.

To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.

Freeze medium
As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
Storage conditions

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Shipping conditions

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Donor

Donor age
73 years
Ethnicity
Caucasian